Bulldog Investors’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,059
Closed -$2.77K 150
2024
Q1
$2.77K Sell
11,059
-449
-4% -$119 ﹤0.01% 141
2023
Q4
$2.22K Sell
11,508
-301
-3% -$73 ﹤0.01% 147
2023
Q3
$2.97K Hold
11,809
﹤0.01% 170
2023
Q2
$4.67K Hold
11,809
﹤0.01% 168
2023
Q1
$3.31K Sell
11,809
-20,995
-64% -$7.96K ﹤0.01% 217
2022
Q4
$8.2K Sell
32,804
-637
-2% -$195 ﹤0.01% 193
2022
Q3
$15K Buy
33,441
+6,769
+25% +$3.99K ﹤0.01% 228
2022
Q2
$13K Sell
26,672
-7,174
-21% -$4K ﹤0.01% 254
2022
Q1
$21K Buy
+33,846
New +$18.5K 0.01% 265

Other funds holding DRTSW

Bulldog Investors's DRTSW Position: Q2 2024 in Review

Bulldog Investors sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2024, closing a stake of 11,059 shares — an estimated $2.77K sold.

Bulldog Investors first reported a position in DRTSW in Q1 2022 and held it in 9 quarters. The position peaked at $21K in Q1 2022. 26 funds tracked by Wall St. Rank hold DRTSW as of Q2 2024.

  • Bulldog Investors reported no remaining Alpha Tau Medical Warrant position as of Q2 2024 after selling out during the quarter.
  • Bulldog Investors sold 11,059 Alpha Tau Medical Warrant shares in Q2 2024, an estimated $2.77K.
  • Bulldog Investors first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 9 quarters.
  • Bulldog Investors's Alpha Tau Medical Warrant position peaked at $21K in Q1 2022.
  • 26 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2024.

Based on Bulldog Investors's 13F filing for Q2 2024, filed 9 Aug 2024.